Anticipating Heron Therapeutics' Breakout on Phase 3 Results
AI Prediction of Heron Therapeutics, Inc. (HRTX)
Heron Therapeutics, with its robust pipeline and strong R&D focus, is poised for potential growth driven by upcoming catalysts, including a major Phase 3 clinical trial result. The company's strategic focus on pharmaceutical preparations positions it well in the biotech sector for a potential breakout.
HRTX Report Information
Prediction Date2025-07-03
Close @ Prediction$2.20
Mkt Cap81m
IPO DateN/a
AI-derived Information
Recent News for HRTX
- Jun 18, 3:28 pm — State of Private Credit Benchmark Report 2026 Q2 Updated Edition: Heron Finance analyzes 69 of the largest private credit funds (PRNewswire RSS)
- Jun 16, 2:49 pm — HRTX files 8-K with regulatory language (ScanScor Filing Bot)
- Jun 2, 11:04 pm — Why Did FULC, MVIS, HRTX Stocks Plunge To 52-Week Lows Today? (Stocktwits)
- Jun 2, 11:30 am — Heron Power Collaborates with LG Energy Solution Vertech, Uniting American-Made Battery Energy Storage Systems and Solid State Transformers to Power the Modern Grid (GlobeNewswire RSS)
- Jun 2, 8:12 am — U.S. District Court Issues Decision Regarding CINVANTI Patents (GlobeNewswire)
- May 12, 3:02 am — Heron Therapeutics Inc (HRTX) Q1 2026 Earnings Call Highlights: Resilient Growth Amidst Challenges (GuruFocus.com)
- May 11, 4:51 pm — Heron Therapeutics, Inc. Q1 2026 Earnings Call Summary (Moby)
- May 11, 11:03 am — Acute Care Revenue Growth Helps Heron (HRTX) Reaffirm 2026 Guidance Despite Q1 Sales Decline (InvestorsHub)
- May 11, 8:07 am — Heron Therapeutics: Q1 Earnings Snapshot (Associated Press)
- May 11, 8:00 am — Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance (GlobeNewswire)
- Apr 27, 5:30 pm — Heron Therapeutics to Report First Quarter 2026 Financial Results on Monday, May 11, 2026 (GlobeNewswire)
- Feb 26, 4:33 pm — Heron Therapeutics, Inc. Q4 2025 Earnings Call Summary (Moby)
Welcome to ScanScor. What you're reading is no ordinary summary -- it's the result of a carefully-crafted interactive session with OpenAI's most advanced models crafted from news, trial details, and financial data. This report attempts to maximize the potential for OpenAI's smartest GPT-based analysis engine, guided by tightly structured prompts to expose the forces behind today's market movers and to predict the future.
Disclaimer: This report is for informational purposes only. It does not constitute financial advice. Always do your own research before making any investment.